CARCINOGENESIS AND CHEMISTRY OF THE CULTIVATED MUSHROOMS
Project Number5R01CA031611-08
Contact PI/Project LeaderTOTH, BELA
Awardee OrganizationUNIVERSITY OF NEBRASKA MEDICAL CENTER
Description
Abstract Text
The commonly eaten, cultivated mushroom, Agaricus bisporus (AB), contains
several N-N-bond-containing chemicals. We demonstrated earlier the
presence, carcinogenicity and mode of action of some of these mushroom
chemicals. In the recent grant, we have shown the carcinogenicity of the
uncooked mushroom and some of its ingredients in long-term experiments
in mice. In addition, we have revealed the presence of two hydrazines:
p-hydrazinobenzoic acid and beta-N-[gammaL(+)-glutamyl]-4-
carboxyphenylhydrazine in the mushroom extracts. Further, we
demonstrated in vitro the metabolism of several mushroom arylhydrazines
using cytochrome P-450 mixed function oxidases and prostaglandin (H)
synthase enzymes. Finally, using purine bases and nucleosides, we have
modeled the reactions of 4-(hydroxymethyl)benzenediazonium ion (HMBD)
with DNA and have observed that HMBD can react with DNA. Secondary
reactions (e.g., cross-linking) may be important. Lastly, we determined
the amount of hydrazines in the mushroom after baking: Only 25% was
destroyed. Also, using the Ames assay we noted no significant difference
between the mutagenic activities of the baked and unbaked mushroom
extracts. In this new continuing proposal, we intend to extend our
investigations to: (1) study the carcinogenicity of baked, lyophilized
and raw AB by using a dose response protocol in lifelong experiments in
mice; (2) reveal the tumorigenicity of 4-(hydroxy-benzenediazonium
sulfate in mice; (3) analyze AB grown by us using radiolabeled compounds
for the presence of diazonium ions and hydrazines; (4) determine the
products of the reaction of HMBD, other diazonium ions and their reactive
species with bases, nucleosides and DNA in vitro at physiological pH and
in isolated cells; and (5) synthesize the above and other chemicals for
analytical chemistry, biochemical and carcinogenicity studies. Positive
findings from this project might have practical implications, because
humans consume mainly baked mushrooms. Further, the mechanistic studies
on mushroom hydrazines and related chemicals might help to reveal their
mode of action on the molecular level. The annual estimated mushroom
consumption in the United States was approximately 435 million kilograms
in 1990-91. The corresponding figure in western Europe was more than 644
million kilograms.
No Sub Projects information available for 5R01CA031611-08
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01CA031611-08
Patents
No Patents information available for 5R01CA031611-08
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01CA031611-08
Clinical Studies
No Clinical Studies information available for 5R01CA031611-08
News and More
Related News Releases
No news release information available for 5R01CA031611-08
History
No Historical information available for 5R01CA031611-08
Similar Projects
No Similar Projects information available for 5R01CA031611-08